Pass the ACDIS Clinical Documentation Specialist CCDS-O Questions and answers with Dumpstech

In CMS-HCC risk adjustment, RAF impact comes from reporting qualifying chronic diseases (HCCs), not from nonspecific symptom-only documentation. “Angina pectoris, unspecified” is frequently a symptom-level statement and, by itself, often does not carry the same risk-adjustment weight as documenting and coding the underlying ischemic heart disease responsible for the angina (for example, coronary artery disease/atherosclerotic heart disease with angina). Ambulatory CDI practice emphasizes that when providers document only “angina,” coders may be limited to a symptom code, which can under-represent the patient’s true disease burden in the HCC model. This makes angina an excellent target for provider education: clarify whether the angina is due to CAD, whether CAD is present and being managed, and whether there are related manifestations (e.g., unstable angina, prior MI history, status post CABG/stent) that support more complete, clinically accurate reporting. By improving documentation linkage from symptom (angina) to the definitive chronic condition (CAD with angina), the provider can more reliably capture an HCC-relevant diagnosis and positively influence RAF accuracy.

Symbicort is an inhaled combination medication containing an inhaled corticosteroid (ICS) and a long-acting beta-agonist (LABA). In outpatient chart review, this medication class is most strongly associated with chronic airway inflammatory diseases requiring controller therapy—especiallypersistent asthma(and also maintenance therapy for COPD, though COPD is not an option here). For CDI purposes, medication-to-diagnosis linkage can act as a clinical indicator supporting clarification when the visit note lists respiratory symptoms but does not clearly document the chronic condition being treated or its acuity/status. Symbicort is not used to treat musculoskeletal degenerative disease (osteoarthritis), peripheral nerve pain from diabetes (diabetic neuropathy), or cardiac pump failure (congestive heart failure). When Symbicort appears on the active med list, outpatient CDI commonly checks that the provider’s documentation appropriately reflects asthma classification (intermittent vs persistent), current control, exacerbation status if applicable, and that the condition is being monitored/assessed/treated during the encounter to support reportability and accurate coding.

For ICD-10-CM injury coding, fracture codes require the correct 7th character to reflect the encounter type and healing status. Because the patient is being seen in the officeaftersurgical treatment (ORIF) and the orthopedist documents the fracture is “healing well without any complication,” this is asubsequent encounter for routine healing, not an initial encounter. Therefore, options A and B are incorrect because they use “initial encounter.” Next, the injury is described as acompound fracture, which is synonymous with anopen fracture. That makes a closed-fracture option inappropriate, eliminating option C. The remaining correct choice is the subsequent-encounter routine-healing option that also identifies the fracture as open. Outpatient CDI principles emphasize ensuring providers document key fracture elements—laterality, anatomic site, open vs closed, and healing status—because these drive compliant code assignment and correct sequencing for follow-up care. While real-world documentation ideally includes Gustilo type specificity, based on the provided choices, the best match is routine healing, subsequent encounter, open fracture.

To support a query foralcohol dependence in remission, outpatient CDI practice looks for indicators that reflect adocumented history of dependenceplus evidence the patient isactively maintaining sobrietyor being followed for recovery status. Attendance atAA meetingstogether with a documented history of excessive alcohol use is a strong, direct indicator of recovery efforts and ongoing monitoring of a prior substance use disorder. This combination supports clarifying whether the provider intends to diagnosealcohol dependence in remission(versus current dependence, use without dependence, or no current disorder). By contrast, cirrhosis and elevated liver enzymes (option A) can be caused by many etiologies and do not, by themselves, establish dependence or remission status. Nausea, vomiting, and abdominal distention (option D) are nonspecific and may suggest acute illness or liver disease but are not specific to remission. Occasional social drinking with recreational drug use (option C) suggests current substance use and would not support “in remission” without additional documentation. Therefore, option B best supports a remission-related query.

In outpatient CDI practice, a common reason to query is a mismatch between what is being evaluated/treated and what is explicitly documented as an active condition for the encounter. A diagnostic chest x-ray aligns with the already-documented symptom (chronic cough), and a nutrition specialist referral aligns with an established diagnosis (obesity); neither inherently suggests an undocumented condition. Prescribing captopril aligns with documented HTN management, so it generally would not create documentation ambiguity requiring clarification (even though ACE inhibitors can be associated with cough, the plan alone does not establish a new reportable diagnosis). In contrast, ordering an HbA1c often signals assessment for diabetes, impaired glucose regulation, or monitoring of known diabetes. Because diabetes is not listed in the history provided, the HbA1c order may prompt the CDI specialist to query whether the provider is evaluating a suspected or existing glycemic disorder, whether there is a diagnosis such as prediabetes/diabetes being addressed, and to ensure the record clearly supports the medical necessity and any reportable condition.

The Relative Factors table shown is a demographic/eligibility-driven component of risk scoring for female beneficiaries, separating patients by setting/status (community vs institutional) and age band. “Institutional” beneficiaries carry higher expected cost because they typically require more resources and support than community patients. In the chart, the institutional relative factor for females age 70–74 is higher than the community factors shown for similar ages and higher than the 90–94 institutional factor displayed. Among the answer choices, option C is the only patient who matches an institutional setting (skilled nursing facility) in the 70–74 age band (72 years). Option D is also institutional, but the table’s 90–94 institutional value is lower than the 70–74 institutional value in this specific chart. Options A and B are community patients, whose relative factors are lower than the institutional values shown. While the listed diagnoses are clinically important and may affect HCC-based risk, the question asks “based on the above chart,” so the highest risk is determined by the chart’s demographic/setting factor—making the 72-year-old institutional patient the highest.

For RAF impact in the CMS-HCC model, the most valuable provider education targets are conditions that (1) map to HCCs or interact with HCC hierarchies, and (2) are clearly within the specialist’s scope to assess and manage during visits. In this scenario, the endocrinologist is actively treatingdiabetesand its complications. Diabetes withperipheral neuropathy/vascular diseaseplus an activenon-healing foot ulcerreflects significant diabetic disease burden and often supports additional required coding (e.g., diabetes complication code plus a separate site/severity ulcer code). The history oftoe amputationsis also important because amputation status can represent ongoing complexity, affects care planning (risk of recurrent ulcer/infection), and may contribute to risk capture depending on the model and associated complications. By contrast, CAD/COPD/HF may not be evaluated by the endocrinologist at the visit, “A1C” is a lab value (not a diagnosis), and “history of prostate cancer” generally does not risk-adjust like active malignancy. Therefore, educating on documenting diabetes, amputation status, and ulcer details best supports RAF accuracy.

When a CDI query references information from an externally shared note, best practice is to include enough identifying detail so the provider can locate and validate the sourceeven if access is later revokedor if the shared record becomes unavailable. From an outpatient CDI and HIPAA-aligned workflow perspective, the query should clearly cite: where the information came from (thelocationof the shared note within the EHR/external record set),whoauthored it (provider name),whenit was created (date of shared note), and thespecific clinical documentationbeing referenced (the relevant statement/findings). This supports transparency, auditability, and minimizes the risk of misattribution or relying on inaccessible information. Options B–D are missing one or more critical elements—most notably the date and/or location of the shared note—making it harder to verify the source. Including “follow-up procedure” is not the priority for HIPAA-compliant source identification; the key need is traceability of the external documentation used to support the clarification request.

RADV (Risk Adjustment Data Validation) is a CMS audit program used in Medicare Advantage to confirm that diagnoses submitted for risk adjustment are supported by medical record documentation and meet reporting requirements. Its central aim ispayment integrity—ensuring that risk-adjusted capitation payments to Medicare Advantage organizations are accurate based on valid, documented conditions. In outpatient CDI practice, RADV risk underscores why documentation must clearly support each reported diagnosis (e.g., condition evaluated/assessed/treated, clinically relevant, and properly documented by an eligible provider), because unsupported diagnoses can lead to payment recoupment and compliance exposure. RADV is not designed to assess medical necessity of the services provided (that is typically addressed through utilization review and other payer audits), nor is it focused on identifying overpayments to individual physicians (it targets plan-level risk adjustment payments). It also is separate from E/M leveling accuracy, which is governed by CPT/E/M guidelines and distinct audit processes. Therefore, the best definition of RADV’s primary purpose is ensuring the integrity and accuracy of risk-adjusted payments.

Outpatient CDI follow-up must balance responsiveness with confidentiality and professional standards. The most compliant approach is to communicate query-related information in a setting that protects protected health information and minimizes the risk of incidental disclosure. Discussing the query in a private room with the door closed supports timely clarification while maintaining privacy, avoiding conversations that could be overheard by patients, visitors, or staff who are not involved in the patient’s care. Catching the provider in the hallway is faster but increases privacy risk because clinical details can be overheard, and it may also distract the provider in a high-traffic environment. Leaving a sticky note on the next patient’s chart is inappropriate because it can be seen by others, may be misplaced, and can create compliance and medico-legal concerns (including mixing patients or leaving PHI unsecured). Waiting for the next scheduled meeting may be compliant but does not support a quick response, potentially delaying coding completion and data integrity. Therefore, a private discussion is both the quickest and most compliant option.